nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—Gemcitabine—breast cancer	0.211	0.445	CbGbCtD
Hydroxyurea—RRM1—Gemcitabine—breast cancer	0.211	0.445	CbGbCtD
Hydroxyurea—CYP2D6—breast cancer	0.198	1	CbGaD
Hydroxyurea—CYP2D6—Idarubicin—breast cancer	0.0214	0.0452	CbGbCtD
Hydroxyurea—CYP2D6—Vinorelbine—breast cancer	0.0105	0.0221	CbGbCtD
Hydroxyurea—CYP2D6—Tamoxifen—breast cancer	0.00945	0.0199	CbGbCtD
Hydroxyurea—CYP2D6—Vinblastine—breast cancer	0.00645	0.0136	CbGbCtD
Hydroxyurea—CYP2D6—Doxorubicin—breast cancer	0.00396	0.00835	CbGbCtD
Hydroxyurea—RRM2—mammary gland—breast cancer	0.00348	0.0844	CbGeAlD
Hydroxyurea—RRM1—mammary gland—breast cancer	0.00289	0.0701	CbGeAlD
Hydroxyurea—RRM1—nipple—breast cancer	0.00239	0.058	CbGeAlD
Hydroxyurea—RRM2—embryo—breast cancer	0.00238	0.0576	CbGeAlD
Hydroxyurea—RRM2—Gefitinib—Lapatinib—breast cancer	0.00191	0.599	CbGdCrCtD
Hydroxyurea—RRM2—skin of body—breast cancer	0.00185	0.0447	CbGeAlD
Hydroxyurea—RRM2—endometrium—breast cancer	0.00174	0.0422	CbGeAlD
Hydroxyurea—RRM2—uterus—breast cancer	0.0016	0.0389	CbGeAlD
Hydroxyurea—RRM2—pituitary gland—breast cancer	0.00157	0.0382	CbGeAlD
Hydroxyurea—RRM2—adipose tissue—breast cancer	0.00157	0.038	CbGeAlD
Hydroxyurea—RRM1—skin of body—breast cancer	0.00153	0.0372	CbGeAlD
Hydroxyurea—RRM1—endometrium—breast cancer	0.00145	0.035	CbGeAlD
Hydroxyurea—RRM2—female reproductive system—breast cancer	0.00144	0.0349	CbGeAlD
Hydroxyurea—RRM2—adrenal gland—breast cancer	0.00141	0.0341	CbGeAlD
Hydroxyurea—RRM2—bone marrow—breast cancer	0.00136	0.033	CbGeAlD
Hydroxyurea—RRM1—uterus—breast cancer	0.00133	0.0323	CbGeAlD
Hydroxyurea—RRM2—female gonad—breast cancer	0.00131	0.0318	CbGeAlD
Hydroxyurea—RRM1—pituitary gland—breast cancer	0.00131	0.0317	CbGeAlD
Hydroxyurea—RRM1—adipose tissue—breast cancer	0.0013	0.0316	CbGeAlD
Hydroxyurea—RRM2—endocrine gland—breast cancer	0.00122	0.0296	CbGeAlD
Hydroxyurea—RRM1—female reproductive system—breast cancer	0.0012	0.029	CbGeAlD
Hydroxyurea—RRM1—adrenal gland—breast cancer	0.00117	0.0283	CbGeAlD
Hydroxyurea—RRM1—bone marrow—breast cancer	0.00113	0.0274	CbGeAlD
Hydroxyurea—RRM1—female gonad—breast cancer	0.00109	0.0264	CbGeAlD
Hydroxyurea—RRM1—endocrine gland—breast cancer	0.00101	0.0246	CbGeAlD
Hydroxyurea—RRM2—lymph node—breast cancer	0.000843	0.0204	CbGeAlD
Hydroxyurea—RRM1—lymph node—breast cancer	0.000701	0.017	CbGeAlD
Hydroxyurea—RRM2—Vinorelbine—Vinblastine—breast cancer	0.000626	0.196	CbGdCrCtD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—breast cancer	0.000402	0.126	CbGdCrCtD
Hydroxyurea—CYP2D6—female reproductive system—breast cancer	0.000356	0.00862	CbGeAlD
Hydroxyurea—CYP2D6—female gonad—breast cancer	0.000324	0.00784	CbGeAlD
Hydroxyurea—CYP2D6—endocrine gland—breast cancer	0.000301	0.00729	CbGeAlD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—breast cancer	0.000252	0.079	CbGdCrCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—SULT1A1—breast cancer	4.92e-05	0.000551	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTA1—breast cancer	4.87e-05	0.000545	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—H2AFX—breast cancer	4.85e-05	0.000542	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.84e-05	0.000541	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—NAT2—breast cancer	4.82e-05	0.000539	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—E2F1—breast cancer	4.81e-05	0.000538	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—NAT2—breast cancer	4.75e-05	0.000532	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.68e-05	0.000524	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CA9—breast cancer	4.65e-05	0.00052	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA4—breast cancer	4.65e-05	0.00052	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK2—breast cancer	4.64e-05	0.000519	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MED12—breast cancer	4.61e-05	0.000515	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—DPYD—breast cancer	4.61e-05	0.000515	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALDOA—breast cancer	4.53e-05	0.000507	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GPX2—breast cancer	4.53e-05	0.000507	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA2—breast cancer	4.53e-05	0.000507	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BIRC5—breast cancer	4.52e-05	0.000506	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SULT1A1—breast cancer	4.48e-05	0.000501	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GPX4—breast cancer	4.48e-05	0.000501	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOA3—breast cancer	4.4e-05	0.000492	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—breast cancer	4.39e-05	0.000491	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TERT—breast cancer	4.38e-05	0.00049	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—GSTA1—breast cancer	4.37e-05	0.000489	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—IDH1—breast cancer	4.37e-05	0.000489	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC2A2—breast cancer	4.37e-05	0.000489	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NAT2—breast cancer	4.33e-05	0.000484	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ABCG2—breast cancer	4.28e-05	0.000479	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—MTR—breast cancer	4.28e-05	0.000479	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CPT1A—breast cancer	4.28e-05	0.000479	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.25e-05	0.000475	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HPGDS—breast cancer	4.2e-05	0.00047	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—HBA1—breast cancer	4.17e-05	0.000467	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDK2—breast cancer	4.15e-05	0.000464	CbGpPWpGaD
Hydroxyurea—Dermatitis—Vinorelbine—breast cancer	4.14e-05	0.000213	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—breast cancer	4.12e-05	0.000212	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Capecitabine—breast cancer	4.12e-05	0.000212	CcSEcCtD
Hydroxyurea—Headache—Vinorelbine—breast cancer	4.11e-05	0.000212	CcSEcCtD
Hydroxyurea—Leukopenia—Docetaxel—breast cancer	4.11e-05	0.000211	CcSEcCtD
Hydroxyurea—Anaemia—Capecitabine—breast cancer	4.11e-05	0.000211	CcSEcCtD
Hydroxyurea—Body temperature increased—Fluorouracil—breast cancer	4.1e-05	0.000211	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GSTT1—breast cancer	4.07e-05	0.000456	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ACHE—breast cancer	4.07e-05	0.000456	CbGpPWpGaD
Hydroxyurea—Weight increased—Epirubicin—breast cancer	4.04e-05	0.000208	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—breast cancer	4.03e-05	0.000207	CcSEcCtD
Hydroxyurea—Malaise—Capecitabine—breast cancer	4.01e-05	0.000206	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—breast cancer	4e-05	0.000206	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mitoxantrone—breast cancer	3.99e-05	0.000206	CcSEcCtD
Hydroxyurea—Hypersensitivity—Irinotecan—breast cancer	3.99e-05	0.000206	CcSEcCtD
Hydroxyurea—Vomiting—Thiotepa—breast cancer	3.99e-05	0.000205	CcSEcCtD
Hydroxyurea—Leukopenia—Capecitabine—breast cancer	3.98e-05	0.000205	CcSEcCtD
Hydroxyurea—Convulsion—Docetaxel—breast cancer	3.98e-05	0.000205	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—breast cancer	3.96e-05	0.000204	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—breast cancer	3.96e-05	0.000204	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—breast cancer	3.96e-05	0.000204	CcSEcCtD
Hydroxyurea—Rash—Thiotepa—breast cancer	3.95e-05	0.000204	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.95e-05	0.000442	CbGpPWpGaD
Hydroxyurea—Dermatitis—Thiotepa—breast cancer	3.95e-05	0.000203	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—ATM—breast cancer	3.94e-05	0.000441	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Paclitaxel—breast cancer	3.94e-05	0.000203	CcSEcCtD
Hydroxyurea—Headache—Thiotepa—breast cancer	3.93e-05	0.000202	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—MTR—breast cancer	3.93e-05	0.000439	CbGpPWpGaD
Hydroxyurea—Somnolence—Paclitaxel—breast cancer	3.93e-05	0.000202	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDK4—breast cancer	3.92e-05	0.000439	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Doxorubicin—breast cancer	3.9e-05	0.000201	CcSEcCtD
Hydroxyurea—Nausea—Vinorelbine—breast cancer	3.9e-05	0.000201	CcSEcCtD
Hydroxyurea—Dyspepsia—Paclitaxel—breast cancer	3.89e-05	0.0002	CcSEcCtD
Hydroxyurea—Asthenia—Mitoxantrone—breast cancer	3.89e-05	0.0002	CcSEcCtD
Hydroxyurea—Asthenia—Irinotecan—breast cancer	3.89e-05	0.0002	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—breast cancer	3.88e-05	0.0002	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	3.88e-05	0.0002	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—breast cancer	3.86e-05	0.000199	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP17A1—breast cancer	3.86e-05	0.000431	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—HPGDS—breast cancer	3.85e-05	0.000431	CbGpPWpGaD
Hydroxyurea—Dysuria—Doxorubicin—breast cancer	3.84e-05	0.000198	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—breast cancer	3.84e-05	0.000198	CcSEcCtD
Hydroxyurea—Decreased appetite—Paclitaxel—breast cancer	3.84e-05	0.000198	CcSEcCtD
Hydroxyurea—Hypersensitivity—Fluorouracil—breast cancer	3.82e-05	0.000197	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—breast cancer	3.82e-05	0.000197	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ENO1—breast cancer	3.82e-05	0.000427	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS1—breast cancer	3.82e-05	0.000427	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—breast cancer	3.81e-05	0.000427	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Paclitaxel—breast cancer	3.81e-05	0.000196	CcSEcCtD
Hydroxyurea—Fatigue—Paclitaxel—breast cancer	3.81e-05	0.000196	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—breast cancer	3.8e-05	0.000196	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MED12—breast cancer	3.79e-05	0.000424	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—DPYD—breast cancer	3.79e-05	0.000424	CbGpPWpGaD
Hydroxyurea—Asthenia—Gemcitabine—breast cancer	3.79e-05	0.000195	CcSEcCtD
Hydroxyurea—Constipation—Paclitaxel—breast cancer	3.78e-05	0.000195	CcSEcCtD
Hydroxyurea—Pain—Paclitaxel—breast cancer	3.78e-05	0.000195	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.76e-05	0.000193	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Epirubicin—breast cancer	3.75e-05	0.000193	CcSEcCtD
Hydroxyurea—Oedema—Docetaxel—breast cancer	3.74e-05	0.000193	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP2D6—breast cancer	3.74e-05	0.000419	CbGpPWpGaD
Hydroxyurea—Weight increased—Doxorubicin—breast cancer	3.74e-05	0.000193	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTT1—breast cancer	3.74e-05	0.000418	CbGpPWpGaD
Hydroxyurea—Discomfort—Capecitabine—breast cancer	3.74e-05	0.000192	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALDOA—breast cancer	3.73e-05	0.000418	CbGpPWpGaD
Hydroxyurea—Nausea—Thiotepa—breast cancer	3.73e-05	0.000192	CcSEcCtD
Hydroxyurea—Infection—Docetaxel—breast cancer	3.72e-05	0.000192	CcSEcCtD
Hydroxyurea—Diarrhoea—Mitoxantrone—breast cancer	3.71e-05	0.000191	CcSEcCtD
Hydroxyurea—Diarrhoea—Irinotecan—breast cancer	3.71e-05	0.000191	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOA2—breast cancer	3.67e-05	0.000411	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Docetaxel—breast cancer	3.67e-05	0.000189	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Docetaxel—breast cancer	3.67e-05	0.000189	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—breast cancer	3.66e-05	0.000189	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—breast cancer	3.66e-05	0.000189	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—breast cancer	3.66e-05	0.000189	CcSEcCtD
Hydroxyurea—Feeling abnormal—Paclitaxel—breast cancer	3.64e-05	0.000187	CcSEcCtD
Hydroxyurea—Skin disorder—Docetaxel—breast cancer	3.64e-05	0.000187	CcSEcCtD
Hydroxyurea—Oedema—Capecitabine—breast cancer	3.63e-05	0.000187	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NCOA3—breast cancer	3.62e-05	0.000405	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Gemcitabine—breast cancer	3.61e-05	0.000186	CcSEcCtD
Hydroxyurea—Infection—Capecitabine—breast cancer	3.6e-05	0.000185	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC2A2—breast cancer	3.6e-05	0.000403	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—breast cancer	3.59e-05	0.000185	CcSEcCtD
Hydroxyurea—Dizziness—Irinotecan—breast cancer	3.58e-05	0.000184	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—breast cancer	3.57e-05	0.000184	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—breast cancer	3.57e-05	0.000184	CcSEcCtD
Hydroxyurea—Anorexia—Docetaxel—breast cancer	3.57e-05	0.000184	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—FASN—breast cancer	3.56e-05	0.000399	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Capecitabine—breast cancer	3.56e-05	0.000183	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—breast cancer	3.55e-05	0.000183	CcSEcCtD
Hydroxyurea—Diarrhoea—Fluorouracil—breast cancer	3.55e-05	0.000183	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Capecitabine—breast cancer	3.55e-05	0.000183	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—BCHE—breast cancer	3.55e-05	0.000397	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP17A1—breast cancer	3.54e-05	0.000396	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—MTR—breast cancer	3.53e-05	0.000394	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CPT1A—breast cancer	3.53e-05	0.000394	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ABCG2—breast cancer	3.53e-05	0.000394	CbGpPWpGaD
Hydroxyurea—Skin disorder—Capecitabine—breast cancer	3.52e-05	0.000181	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—SLC5A5—breast cancer	3.5e-05	0.000392	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—PTGS1—breast cancer	3.5e-05	0.000392	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Paclitaxel—breast cancer	3.49e-05	0.00018	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP17A1—breast cancer	3.49e-05	0.00039	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—breast cancer	3.47e-05	0.000178	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HPGDS—breast cancer	3.46e-05	0.000387	CbGpPWpGaD
Hydroxyurea—Anorexia—Capecitabine—breast cancer	3.46e-05	0.000178	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—breast cancer	3.45e-05	0.000177	CcSEcCtD
Hydroxyurea—Vomiting—Mitoxantrone—breast cancer	3.44e-05	0.000177	CcSEcCtD
Hydroxyurea—Vomiting—Irinotecan—breast cancer	3.44e-05	0.000177	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HBA1—breast cancer	3.44e-05	0.000384	CbGpPWpGaD
Hydroxyurea—Dizziness—Fluorouracil—breast cancer	3.43e-05	0.000177	CcSEcCtD
Hydroxyurea—Rash—Mitoxantrone—breast cancer	3.42e-05	0.000176	CcSEcCtD
Hydroxyurea—Rash—Irinotecan—breast cancer	3.42e-05	0.000176	CcSEcCtD
Hydroxyurea—Dermatitis—Mitoxantrone—breast cancer	3.41e-05	0.000176	CcSEcCtD
Hydroxyurea—Dermatitis—Irinotecan—breast cancer	3.41e-05	0.000176	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—breast cancer	3.41e-05	0.000382	CbGpPWpGaD
Hydroxyurea—Chills—Methotrexate—breast cancer	3.41e-05	0.000176	CcSEcCtD
Hydroxyurea—Headache—Mitoxantrone—breast cancer	3.39e-05	0.000175	CcSEcCtD
Hydroxyurea—Headache—Irinotecan—breast cancer	3.39e-05	0.000175	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NQO1—breast cancer	3.38e-05	0.000379	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC2A1—breast cancer	3.38e-05	0.000379	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—NCOA2—breast cancer	3.37e-05	0.000377	CbGpPWpGaD
Hydroxyurea—Alopecia—Methotrexate—breast cancer	3.36e-05	0.000173	CcSEcCtD
Hydroxyurea—Vomiting—Gemcitabine—breast cancer	3.35e-05	0.000173	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTT1—breast cancer	3.35e-05	0.000375	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ACHE—breast cancer	3.35e-05	0.000375	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Docetaxel—breast cancer	3.34e-05	0.000172	CcSEcCtD
Hydroxyurea—Somnolence—Docetaxel—breast cancer	3.33e-05	0.000171	CcSEcCtD
Hydroxyurea—Rash—Gemcitabine—breast cancer	3.33e-05	0.000171	CcSEcCtD
Hydroxyurea—Dermatitis—Gemcitabine—breast cancer	3.32e-05	0.000171	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—breast cancer	3.31e-05	0.00017	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—breast cancer	3.31e-05	0.00017	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—breast cancer	3.31e-05	0.00017	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP3A4—breast cancer	3.3e-05	0.000369	CbGpPWpGaD
Hydroxyurea—Vomiting—Fluorouracil—breast cancer	3.3e-05	0.00017	CcSEcCtD
Hydroxyurea—Dyspepsia—Docetaxel—breast cancer	3.3e-05	0.00017	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—breast cancer	3.29e-05	0.000169	CcSEcCtD
Hydroxyurea—Rash—Fluorouracil—breast cancer	3.27e-05	0.000168	CcSEcCtD
Hydroxyurea—Dermatitis—Fluorouracil—breast cancer	3.27e-05	0.000168	CcSEcCtD
Hydroxyurea—Decreased appetite—Docetaxel—breast cancer	3.25e-05	0.000168	CcSEcCtD
Hydroxyurea—Hypersensitivity—Paclitaxel—breast cancer	3.25e-05	0.000168	CcSEcCtD
Hydroxyurea—Headache—Fluorouracil—breast cancer	3.25e-05	0.000167	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1B1—breast cancer	3.25e-05	0.000363	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Docetaxel—breast cancer	3.23e-05	0.000166	CcSEcCtD
Hydroxyurea—Dyspnoea—Capecitabine—breast cancer	3.23e-05	0.000166	CcSEcCtD
Hydroxyurea—Fatigue—Docetaxel—breast cancer	3.23e-05	0.000166	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—breast cancer	3.23e-05	0.000166	CcSEcCtD
Hydroxyurea—Nausea—Irinotecan—breast cancer	3.22e-05	0.000166	CcSEcCtD
Hydroxyurea—Nausea—Mitoxantrone—breast cancer	3.22e-05	0.000166	CcSEcCtD
Hydroxyurea—Constipation—Docetaxel—breast cancer	3.2e-05	0.000165	CcSEcCtD
Hydroxyurea—Pain—Docetaxel—breast cancer	3.2e-05	0.000165	CcSEcCtD
Hydroxyurea—Dyspepsia—Capecitabine—breast cancer	3.19e-05	0.000164	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—breast cancer	3.19e-05	0.000164	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—HSP90AA1—breast cancer	3.18e-05	0.000356	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP17A1—breast cancer	3.17e-05	0.000355	CbGpPWpGaD
Hydroxyurea—Asthenia—Paclitaxel—breast cancer	3.17e-05	0.000163	CcSEcCtD
Hydroxyurea—Decreased appetite—Capecitabine—breast cancer	3.15e-05	0.000162	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PTGS1—breast cancer	3.14e-05	0.000352	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO1—breast cancer	3.14e-05	0.000352	CbGpPWpGaD
Hydroxyurea—Alopecia—Epirubicin—breast cancer	3.14e-05	0.000162	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—breast cancer	3.13e-05	0.000161	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Capecitabine—breast cancer	3.13e-05	0.000161	CcSEcCtD
Hydroxyurea—Fatigue—Capecitabine—breast cancer	3.13e-05	0.000161	CcSEcCtD
Hydroxyurea—Constipation—Capecitabine—breast cancer	3.1e-05	0.00016	CcSEcCtD
Hydroxyurea—Pain—Capecitabine—breast cancer	3.1e-05	0.00016	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NCOA1—breast cancer	3.1e-05	0.000346	CbGpPWpGaD
Hydroxyurea—Erythema—Epirubicin—breast cancer	3.09e-05	0.000159	CcSEcCtD
Hydroxyurea—Feeling abnormal—Docetaxel—breast cancer	3.09e-05	0.000159	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP2D6—breast cancer	3.08e-05	0.000345	CbGpPWpGaD
Hydroxyurea—Nausea—Fluorouracil—breast cancer	3.08e-05	0.000159	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—breast cancer	3.07e-05	0.000158	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—breast cancer	3.06e-05	0.000157	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP19A1—breast cancer	3.05e-05	0.000341	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—STK11—breast cancer	3.05e-05	0.000341	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP3A4—breast cancer	3.03e-05	0.000339	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOA2—breast cancer	3.03e-05	0.000338	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Paclitaxel—breast cancer	3.02e-05	0.000156	CcSEcCtD
Hydroxyurea—Feeling abnormal—Capecitabine—breast cancer	2.99e-05	0.000154	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP3A4—breast cancer	2.99e-05	0.000334	CbGpPWpGaD
Hydroxyurea—Angiopathy—Doxorubicin—breast cancer	2.98e-05	0.000154	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—breast cancer	2.98e-05	0.000154	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1B1—breast cancer	2.98e-05	0.000333	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1B—breast cancer	2.97e-05	0.000332	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Docetaxel—breast cancer	2.96e-05	0.000152	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—breast cancer	2.96e-05	0.000152	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—breast cancer	2.95e-05	0.000152	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1B1—breast cancer	2.94e-05	0.000328	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—FASN—breast cancer	2.93e-05	0.000328	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—BCHE—breast cancer	2.92e-05	0.000327	CbGpPWpGaD
Hydroxyurea—Dizziness—Paclitaxel—breast cancer	2.92e-05	0.00015	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MDM2—breast cancer	2.91e-05	0.000325	CbGpPWpGaD
Hydroxyurea—Alopecia—Doxorubicin—breast cancer	2.91e-05	0.00015	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC5A5—breast cancer	2.89e-05	0.000323	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—breast cancer	2.87e-05	0.000148	CcSEcCtD
Hydroxyurea—Body temperature increased—Capecitabine—breast cancer	2.87e-05	0.000148	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—breast cancer	2.87e-05	0.000148	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—breast cancer	2.86e-05	0.000147	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—breast cancer	2.86e-05	0.000147	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—NCOA1—breast cancer	2.84e-05	0.000318	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—COMT—breast cancer	2.84e-05	0.000317	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—breast cancer	2.83e-05	0.000317	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTP1—breast cancer	2.82e-05	0.000316	CbGpPWpGaD
Hydroxyurea—Vomiting—Paclitaxel—breast cancer	2.81e-05	0.000145	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP19A1—breast cancer	2.8e-05	0.000313	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.8e-05	0.000144	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—breast cancer	2.79e-05	0.000144	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—NQO1—breast cancer	2.79e-05	0.000312	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SLC2A1—breast cancer	2.79e-05	0.000312	CbGpPWpGaD
Hydroxyurea—Rash—Paclitaxel—breast cancer	2.79e-05	0.000143	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—HMOX1—breast cancer	2.78e-05	0.000311	CbGpPWpGaD
Hydroxyurea—Dermatitis—Paclitaxel—breast cancer	2.78e-05	0.000143	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—breast cancer	2.78e-05	0.000143	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ITPR1—breast cancer	2.78e-05	0.000311	CbGpPWpGaD
Hydroxyurea—Leukopenia—Epirubicin—breast cancer	2.77e-05	0.000143	CcSEcCtD
Hydroxyurea—Headache—Paclitaxel—breast cancer	2.77e-05	0.000143	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP19A1—breast cancer	2.76e-05	0.000309	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Docetaxel—breast cancer	2.76e-05	0.000142	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN1A—breast cancer	2.74e-05	0.000307	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP3A4—breast cancer	2.72e-05	0.000304	CbGpPWpGaD
Hydroxyurea—Asthenia—Docetaxel—breast cancer	2.69e-05	0.000138	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—breast cancer	2.68e-05	0.000138	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—breast cancer	2.68e-05	0.000138	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ABCB1—breast cancer	2.67e-05	0.000299	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP1B1—breast cancer	2.67e-05	0.000299	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Capecitabine—breast cancer	2.67e-05	0.000138	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—breast cancer	2.66e-05	0.000137	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN1B—breast cancer	2.66e-05	0.000297	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Methotrexate—breast cancer	2.65e-05	0.000136	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—breast cancer	2.65e-05	0.000136	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—breast cancer	2.64e-05	0.000136	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMS—breast cancer	2.62e-05	0.000294	CbGpPWpGaD
Hydroxyurea—Nausea—Paclitaxel—breast cancer	2.62e-05	0.000135	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—breast cancer	2.62e-05	0.000135	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—HSP90AA1—breast cancer	2.62e-05	0.000293	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.62e-05	0.000135	CcSEcCtD
Hydroxyurea—Discomfort—Epirubicin—breast cancer	2.6e-05	0.000134	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—COMT—breast cancer	2.6e-05	0.000291	CbGpPWpGaD
Hydroxyurea—Asthenia—Capecitabine—breast cancer	2.6e-05	0.000134	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PLA2G4A—breast cancer	2.59e-05	0.00029	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GSTM1—breast cancer	2.59e-05	0.00029	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NCOR1—breast cancer	2.59e-05	0.00029	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—GSTP1—breast cancer	2.59e-05	0.00029	CbGpPWpGaD
Hydroxyurea—Malaise—Doxorubicin—breast cancer	2.58e-05	0.000133	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—breast cancer	2.57e-05	0.000132	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—COMT—breast cancer	2.57e-05	0.000287	CbGpPWpGaD
Hydroxyurea—Leukopenia—Doxorubicin—breast cancer	2.56e-05	0.000132	CcSEcCtD
Hydroxyurea—Diarrhoea—Docetaxel—breast cancer	2.56e-05	0.000132	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTP1—breast cancer	2.55e-05	0.000286	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOA1—breast cancer	2.55e-05	0.000285	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—breast cancer	2.53e-05	0.000283	CbGpPWpGaD
Hydroxyurea—Oedema—Epirubicin—breast cancer	2.53e-05	0.00013	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—STK11—breast cancer	2.51e-05	0.000281	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP19A1—breast cancer	2.51e-05	0.000281	CbGpPWpGaD
Hydroxyurea—Infection—Epirubicin—breast cancer	2.51e-05	0.000129	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GPX1—breast cancer	2.48e-05	0.000278	CbGpPWpGaD
Hydroxyurea—Convulsion—Doxorubicin—breast cancer	2.48e-05	0.000128	CcSEcCtD
Hydroxyurea—Diarrhoea—Capecitabine—breast cancer	2.48e-05	0.000128	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—breast cancer	2.48e-05	0.000128	CcSEcCtD
Hydroxyurea—Dizziness—Docetaxel—breast cancer	2.48e-05	0.000128	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—breast cancer	2.47e-05	0.000127	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP1A1—breast cancer	2.46e-05	0.000275	CbGpPWpGaD
Hydroxyurea—Skin disorder—Epirubicin—breast cancer	2.45e-05	0.000126	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN1A—breast cancer	2.45e-05	0.000274	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ERCC2—breast cancer	2.44e-05	0.000273	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.42e-05	0.000125	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—breast cancer	2.41e-05	0.000124	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—breast cancer	2.41e-05	0.000124	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—breast cancer	2.41e-05	0.000124	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—breast cancer	2.4e-05	0.000124	CcSEcCtD
Hydroxyurea—Dizziness—Capecitabine—breast cancer	2.4e-05	0.000123	CcSEcCtD
Hydroxyurea—Vomiting—Docetaxel—breast cancer	2.38e-05	0.000123	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—GSTM1—breast cancer	2.38e-05	0.000266	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Methotrexate—breast cancer	2.38e-05	0.000122	CcSEcCtD
Hydroxyurea—Rash—Docetaxel—breast cancer	2.36e-05	0.000122	CcSEcCtD
Hydroxyurea—Dermatitis—Docetaxel—breast cancer	2.36e-05	0.000121	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	2.35e-05	0.000263	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Methotrexate—breast cancer	2.35e-05	0.000121	CcSEcCtD
Hydroxyurea—Headache—Docetaxel—breast cancer	2.35e-05	0.000121	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—breast cancer	2.34e-05	0.00012	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK3—breast cancer	2.34e-05	0.000261	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—COMT—breast cancer	2.34e-05	0.000261	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—breast cancer	2.33e-05	0.00012	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—breast cancer	2.33e-05	0.00012	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTP1—breast cancer	2.32e-05	0.00026	CbGpPWpGaD
Hydroxyurea—Infection—Doxorubicin—breast cancer	2.32e-05	0.00012	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—breast cancer	2.31e-05	0.000119	CcSEcCtD
Hydroxyurea—Vomiting—Capecitabine—breast cancer	2.31e-05	0.000119	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—MTHFR—breast cancer	2.29e-05	0.000256	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—HMOX1—breast cancer	2.29e-05	0.000256	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Doxorubicin—breast cancer	2.29e-05	0.000118	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Doxorubicin—breast cancer	2.29e-05	0.000118	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ITPR1—breast cancer	2.29e-05	0.000256	CbGpPWpGaD
Hydroxyurea—Rash—Capecitabine—breast cancer	2.29e-05	0.000118	CcSEcCtD
Hydroxyurea—Dermatitis—Capecitabine—breast cancer	2.28e-05	0.000118	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—breast cancer	2.27e-05	0.000254	CbGpPWpGaD
Hydroxyurea—Headache—Capecitabine—breast cancer	2.27e-05	0.000117	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—breast cancer	2.27e-05	0.000117	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP1A1—breast cancer	2.26e-05	0.000252	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Epirubicin—breast cancer	2.25e-05	0.000116	CcSEcCtD
Hydroxyurea—Somnolence—Epirubicin—breast cancer	2.25e-05	0.000116	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—breast cancer	2.23e-05	0.000115	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	2.23e-05	0.000249	CbGpPWpGaD
Hydroxyurea—Nausea—Docetaxel—breast cancer	2.22e-05	0.000115	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—breast cancer	2.22e-05	0.000115	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—breast cancer	2.22e-05	0.000114	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ABCB1—breast cancer	2.2e-05	0.000246	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Epirubicin—breast cancer	2.2e-05	0.000113	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—breast cancer	2.18e-05	0.000112	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—breast cancer	2.18e-05	0.000112	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMS—breast cancer	2.16e-05	0.000242	CbGpPWpGaD
Hydroxyurea—Constipation—Epirubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Hydroxyurea—Pain—Epirubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Hydroxyurea—Nausea—Capecitabine—breast cancer	2.15e-05	0.000111	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GSTM1—breast cancer	2.14e-05	0.000239	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PLA2G4A—breast cancer	2.14e-05	0.000239	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NCOR1—breast cancer	2.14e-05	0.000239	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Methotrexate—breast cancer	2.13e-05	0.00011	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CAV1—breast cancer	2.11e-05	0.000237	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAPK3—breast cancer	2.09e-05	0.000234	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—breast cancer	2.08e-05	0.000107	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—breast cancer	2.08e-05	0.000107	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—breast cancer	2.08e-05	0.000107	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—breast cancer	2.06e-05	0.000106	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GPX1—breast cancer	2.05e-05	0.000229	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—breast cancer	2.03e-05	0.000227	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Doxorubicin—breast cancer	2.03e-05	0.000105	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP1A1—breast cancer	2.03e-05	0.000227	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—breast cancer	2.02e-05	0.000104	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—breast cancer	2.01e-05	0.000104	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ERCC2—breast cancer	2.01e-05	0.000225	CbGpPWpGaD
Hydroxyurea—Constipation—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—breast cancer	1.99e-05	0.000102	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—breast cancer	1.94e-05	9.97e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CG—breast cancer	1.93e-05	0.000215	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—breast cancer	1.93e-05	9.92e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—MTHFR—breast cancer	1.89e-05	0.000211	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Epirubicin—breast cancer	1.86e-05	9.58e-05	CcSEcCtD
Hydroxyurea—Body temperature increased—Doxorubicin—breast cancer	1.85e-05	9.51e-05	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—breast cancer	1.85e-05	9.51e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—SYNJ2—breast cancer	1.82e-05	0.000203	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—breast cancer	1.81e-05	9.33e-05	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—breast cancer	1.78e-05	9.19e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CAV1—breast cancer	1.74e-05	0.000195	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Epirubicin—breast cancer	1.73e-05	8.9e-05	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—breast cancer	1.72e-05	8.87e-05	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—breast cancer	1.72e-05	8.84e-05	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—breast cancer	1.7e-05	8.76e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—breast cancer	1.7e-05	8.75e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CD—breast cancer	1.69e-05	0.000189	CbGpPWpGaD
Hydroxyurea—Headache—Methotrexate—breast cancer	1.69e-05	8.71e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—NDUFS3—breast cancer	1.69e-05	0.000189	CbGpPWpGaD
Hydroxyurea—Asthenia—Doxorubicin—breast cancer	1.68e-05	8.63e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ALB—breast cancer	1.67e-05	0.000187	CbGpPWpGaD
Hydroxyurea—Dizziness—Epirubicin—breast cancer	1.67e-05	8.6e-05	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TP53—breast cancer	1.67e-05	0.000187	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—breast cancer	1.61e-05	8.27e-05	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—breast cancer	1.6e-05	8.26e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—NOS3—breast cancer	1.6e-05	0.000179	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Doxorubicin—breast cancer	1.6e-05	8.23e-05	CcSEcCtD
Hydroxyurea—Rash—Epirubicin—breast cancer	1.59e-05	8.2e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—breast cancer	1.59e-05	8.19e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—CHST9—breast cancer	1.59e-05	0.000177	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—breast cancer	1.59e-05	0.000177	CbGpPWpGaD
Hydroxyurea—Headache—Epirubicin—breast cancer	1.58e-05	8.15e-05	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—breast cancer	1.55e-05	7.96e-05	CcSEcCtD
Hydroxyurea—CYP2D6—Metabolism—COX11—breast cancer	1.5e-05	0.000168	CbGpPWpGaD
Hydroxyurea—Nausea—Epirubicin—breast cancer	1.5e-05	7.73e-05	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—breast cancer	1.49e-05	7.65e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CB—breast cancer	1.48e-05	0.000165	CbGpPWpGaD
Hydroxyurea—Rash—Doxorubicin—breast cancer	1.47e-05	7.59e-05	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—breast cancer	1.47e-05	7.58e-05	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—breast cancer	1.46e-05	7.54e-05	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PTGS2—breast cancer	1.46e-05	0.000164	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CD—breast cancer	1.39e-05	0.000156	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—breast cancer	1.39e-05	7.15e-05	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ALB—breast cancer	1.38e-05	0.000154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CDA—breast cancer	1.38e-05	0.000154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SHMT1—breast cancer	1.38e-05	0.000154	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A5—breast cancer	1.32e-05	0.000148	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.32e-05	0.000148	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NOS3—breast cancer	1.32e-05	0.000147	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APRT—breast cancer	1.28e-05	0.000143	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—breast cancer	1.28e-05	0.000143	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—breast cancer	1.22e-05	0.000136	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—breast cancer	1.2e-05	0.000135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ESRRA—breast cancer	1.2e-05	0.000135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.2e-05	0.000135	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HADHB—breast cancer	1.14e-05	0.000128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPI—breast cancer	1.14e-05	0.000128	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.09e-05	0.000122	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.09e-05	0.000122	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ADSL—breast cancer	1.04e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FHL2—breast cancer	1.04e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NME1—breast cancer	1.04e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PHGDH—breast cancer	1.04e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—UMPS—breast cancer	1.04e-05	0.000117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPSE—breast cancer	1.02e-05	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BRIP1—breast cancer	1.02e-05	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—LDHB—breast cancer	1.02e-05	0.000114	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCC1—breast cancer	9.69e-06	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA3—breast cancer	9.69e-06	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HMMR—breast cancer	9.69e-06	0.000108	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARGC1B—breast cancer	9.39e-06	0.000105	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—breast cancer	9e-06	0.000101	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CA9—breast cancer	8.86e-06	9.92e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA4—breast cancer	8.86e-06	9.92e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA2—breast cancer	8.64e-06	9.66e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPX2—breast cancer	8.64e-06	9.66e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SULT1A1—breast cancer	8.53e-06	9.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPX4—breast cancer	8.53e-06	9.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH1—breast cancer	8.33e-06	9.32e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTA1—breast cancer	8.33e-06	9.32e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NAT2—breast cancer	8.24e-06	9.22e-05	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—breast cancer	7.41e-06	8.29e-05	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—breast cancer	7.35e-06	8.22e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DPYD—breast cancer	7.23e-06	8.08e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MED12—breast cancer	7.23e-06	8.08e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALDOA—breast cancer	7.11e-06	7.96e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA3—breast cancer	6.91e-06	7.73e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A2—breast cancer	6.86e-06	7.67e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CPT1A—breast cancer	6.72e-06	7.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTR—breast cancer	6.72e-06	7.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCG2—breast cancer	6.72e-06	7.52e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HPGDS—breast cancer	6.59e-06	7.37e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HBA1—breast cancer	6.55e-06	7.32e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ACHE—breast cancer	6.39e-06	7.15e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTT1—breast cancer	6.39e-06	7.15e-05	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—breast cancer	6.05e-06	6.77e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP17A1—breast cancer	6.05e-06	6.77e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO1—breast cancer	5.99e-06	6.7e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS1—breast cancer	5.99e-06	6.7e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA2—breast cancer	5.76e-06	6.45e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—FASN—breast cancer	5.59e-06	6.25e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCHE—breast cancer	5.57e-06	6.23e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC5A5—breast cancer	5.5e-06	6.15e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A1—breast cancer	5.31e-06	5.94e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NQO1—breast cancer	5.31e-06	5.94e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP3A4—breast cancer	5.18e-06	5.79e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1B1—breast cancer	5.09e-06	5.7e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.99e-06	5.59e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOA1—breast cancer	4.86e-06	5.43e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STK11—breast cancer	4.79e-06	5.35e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP19A1—breast cancer	4.79e-06	5.35e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—COMT—breast cancer	4.45e-06	4.98e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTP1—breast cancer	4.43e-06	4.95e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—HMOX1—breast cancer	4.37e-06	4.89e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ITPR1—breast cancer	4.36e-06	4.88e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ABCB1—breast cancer	4.19e-06	4.69e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMS—breast cancer	4.12e-06	4.61e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.07e-06	4.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GSTM1—breast cancer	4.07e-06	4.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NCOR1—breast cancer	4.07e-06	4.55e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPX1—breast cancer	3.9e-06	4.36e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP1A1—breast cancer	3.86e-06	4.32e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ERCC2—breast cancer	3.83e-06	4.28e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—MTHFR—breast cancer	3.6e-06	4.02e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAV1—breast cancer	3.32e-06	3.71e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—breast cancer	3.02e-06	3.38e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—breast cancer	2.66e-06	2.97e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALB—breast cancer	2.62e-06	2.93e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NOS3—breast cancer	2.51e-06	2.81e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—breast cancer	2.32e-06	2.59e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—breast cancer	2.29e-06	2.57e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—breast cancer	2e-06	2.24e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—breast cancer	1.41e-06	1.58e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—breast cancer	1.15e-06	1.29e-05	CbGpPWpGaD
